Health Catalyst Inc. reported third quarter 2025 financial results with total revenue of $76.3 million, nearly unchanged from the $76.4 million reported in the same period of 2024. Gross profit rose by 8% to $30.0 million, with gross margin increasing to 39% from 36%. The company recorded a net loss of $22.2 million, compared to a net loss of $14.7 million in the third quarter of 2024. Adjusted gross profit grew by 11% to $40.1 million, and adjusted gross margin improved to 53% from 48%. Adjusted EBITDA increased by 64% to $12.0 million. Health Catalyst reaffirmed its full-year 2025 guidance, expecting total revenue of approximately $310.0 million and adjusted EBITDA of around $41.0 million. The company highlighted its focus on high-impact solutions, strategic focus, cost management, and targeted investments as key business developments for the period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health Catalyst Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9572808-en) on November 10, 2025, and is solely responsible for the information contained therein.
Comments